BioSpace News Archive

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that it has entered into a clinical trial collaboration with AstraZeneca (LSE/STO/NYSE: AZN) to evaluate the combination of patritumab deruxtecan (U3-1402), a HER3 directed DXd antibody drug conjugate (ADC), and TAGRISSO (osimertinib), an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), in patients wi

Nordic Nanovector ASA announces that, following a planned interim analysis of the PARADIGME Phase 2b pivotal trial of Betalutin® in patients with relapsed/refractory follicular lymphoma, the Independent Review Committee has recommended Nordic Nanovector to focus on one dosage arm to completion.

Nolato has signed an agreement to acquire US-based GW Plastics. The company, which was founded in 1955, has annual sales of approximately SEK 1.8 billion and an EBITA margin of around 7%.

RNA-based gene silencing has been heralded a novel means for drug target identification and validation.

The global veterinary patients monitor market is foreseen to experience remarkable growth avenues during the forecast period of 2019 to 2029.

The shareholders of the medical imaging IT and cyber security company Sectra AB are hereby invited to the Annual General Meeting held on Tuesday, September 8, 2020 at 3.30 p.m. at Collegium, Teknikringen 7, Linköping, Sweden.

According to the report by Transparency Market Research, the global interventional cardiology devices market has highly consolidated landscape.

Bone morphogenetic proteins that have been classified under transforming growth factor beta super family are considered as multi-factorial growth factors.

With a large pool of vendors of acute care needleless connectors across the world, the global acute care needleless connectors market are displaying a highly competitive business landscape, states a new study by Transparency Market Research.

Clopidogrel has remained, ever since its first approval in 1997, the antiplatelet therapy of choice among physicians for the treatment of patients with conditions such as acute coronary syndrome or percutaneous coronary intervention.